Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00649025 · ClinicalTrials.gov registry record · Phase 3
A Study Comparing the Safety and Efficacy of Fluticasone and Formoterol Combination (FlutiForm™) With Fluticasone or Flovent to Treat Moderate to Severe Asthma in Adolescents and Adults
A Phase 3 study, sponsored by SkyePharma.
- Completed
- Registry status
- Phase 3
- Development phase
- 438
- Enrollment target
NCT00649025: Completed Phase 3 study, sponsored by SkyePharma.
NCT00649025 is a Phase 3 study that has completed, run by SkyePharma. The registered enrollment target is 438 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (43% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00649025, a Phase 3 study, has completed, sponsored by SkyePharma.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 438 participants
- Enrollment target
Study Summary
The medications being used in this study are individually approved by the Food and Drug Administration (FDA). The medication under investigation is a combination of two medications in one inhaler. The purpose of this study is to determine how well your asthma is controlled when taking one of the three treatment.
Interventions
- DRUG FlutiForm 250/10
- DRUG SKP-Fluticasone
- DRUG Flovent Fluticasone HFA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 438 participants |
| Start Date | 2008-03 |
| Est. Completion | 2008-10 |
| Phase | Phase 3 |
What the finished NCT00649025 record still lists
NCT00649025 is an interventional study that assigns participants to a tested intervention. The registered 438 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (43% lower).
The record links to 0 conditions, and to 3 interventions - of which FlutiForm 250/10 is the first listed.
NCT00649025 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00649025 about?
NCT00649025 is a clinical study titled "A Study Comparing the Safety and Efficacy of Fluticasone and Formoterol Combination (FlutiForm™) With Fluticasone or Flovent to Treat Moderate to Severe Asthma in Adolescents and Adults". The medications being used in this study are individually approved by the Food and Drug Administration (FDA). The medication under investigation is a combination of two medications in one inhaler. The purpose of this study is to determine how well your asthma is controlled when taking one of the thr...
What is the current status of trial NCT00649025?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 438 participants. The study started on 2008-03. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00649025?
The interventions under investigation include: FlutiForm 250/10 (DRUG), SKP-Fluticasone (DRUG), Flovent Fluticasone HFA (DRUG).
Who is sponsoring clinical trial NCT00649025?
This trial is sponsored by SkyePharma, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00649025's enrollment target sits among peer trials
438 874th of 2000 higher than 1,127 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05711446 · 438 participants · NA
Double Voiding and Post-transplant UTI
- NCT05421663 · 439 participants · Phase 1
A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma
- NCT06235151 · 439 participants · Phase 3
Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer
- NCT05114538 · 440 participants · NA
Improving the Part C Early Intervention Service Delivery System for Children with ASD
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia